Related references
Note: Only part of the references are listed.Effect of aminoguanidine on lipopolysaccharide-induced changes in rat liver transporters and transcription factors
Kimiko Aoki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2008)
P-glycoprotein function and expression during obstructive cholestasis in rats
Stanislav Micuda et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2008)
Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia
Suzanne Heemskerk et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2007)
Effect of methotrexate treatment on expression levels of multidrug resistance protein 2, breast cancer resistance protein and organic anion transporters Oat1, Oat2 and Oat3 in rats
Yoshihiko Shibayama et al.
CANCER SCIENCE (2006)
Pharmacogenomics of human OATP transporters
J König et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Gabriele Jedlitschky et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Effect of oral colestimide on the elimination of high-dose methotrexate in patients with primary central nervous system lymphoma - Two case reports
K Makino et al.
NEUROLOGIA MEDICO-CHIRURGICA (2005)
Differential induction of adrenomedullin, interleukins and tumour necrosis factor-α by lipopolysaccharide in rat tissues in vivo
YY Li et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2005)
CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice
M Wagner et al.
HEPATOLOGY (2005)
Experimental LPS-induced cholestasis alters subcellular distribution and affects colocalization of Mrp2 and Bsep proteins: A quantitative colocalization study
V Zinchuk et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2005)
Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats
M Kuroda et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Lipopolysaccharide-mediated regulation of hepatic transporter mRNA levels in rats
NJ Cherrington et al.
DRUG METABOLISM AND DISPOSITION (2004)
Comparison of urinary excretion of pravastatin and temocapril in bile duct-ligated rats and Eisai hyperbilirubinemic rats (EHBR)
Y Takada et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2004)
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
G Zollner et al.
JOURNAL OF HEPATOLOGY (2003)
Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2
K Hidemura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Impact of mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats
CP Chen et al.
PHARMACEUTICAL RESEARCH (2003)
Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases
J Grim et al.
CLINICAL PHARMACOKINETICS (2003)
Shiga-Like toxin II derived from Escherichia coli O157:H7 modifies renal handling of levofloxacin in rats
YL Zhao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice
Y Tanaka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Effect of endotoxin on P-glycoprotein-mediated biliary and renal excretion of rhodamine-123 in rats
H Ando et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Factors influencing the inhibition of biliary glutathione efflux induced by biliary obstruction
A Pastor et al.
LIFE SCIENCES (2000)
Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver
CC Paulusma et al.
HEPATOLOGY (2000)
Share Paper
